GLIOBLASTOM - Anni Hofmann Stiftung

Interim reports of the current funding period (January 2016 - December 2017)

On Nov-14-2016 a conference was held by the advisory board and promoted researchers. During this conference they presented their interim reports concerning their latest progress. These reports are elaborated upon in more details below:

1. Prof. Dr. Glass: “The dual role of mesenchymal stem cells in gliomas: new therapies and therapeutic targets.”

2. Prof. Dr. Lamszus: "Tumor metabolism - interaction between glioblastoma cells and brain"

3. Prof. Dr. Herold-Mende: “Immunological changes and adaptation of the tumor microenvironment during glioblastoma progression”

New therapies and therapeutic target

On May 16th a conference was held by the advisory board and promoted researchers. During this conference they presented their interim reports concering their latest progress. These reports are elaborated upon in more details below:

Immunological changes and adaptation of the tumor microenvironment during glioblastoma progression - state may 2014 -